New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
09:06 EDTNUVA, THOR, ELGX, BSX, STJ, DGX, ABCO, FLDM, CMNPiper Jaffray's technical analyst holds an analyst/industry conference call
Technical Analyst Johnson provides a technical review of the firm's Medical Technology covered universe ahead of 4Q results on an Analyst/Industry conference call to be held on January 10 at 10 am.
News For ABCO;BSX;CMN;DGX;ELGX;FLDM;STJ;THOR;NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 1, 2015
08:37 EDTNUVANuVasive sees Q1 revenue exceeding $190M, consensus $189.32M
NuVasive announced that it anticipates Q1 revenue will be in excess of $190M, including more than $2M of currency headwinds, and remains on track for 2015 profitability goals. The company will announce complete financial and operating results on Q1 performance and review its guidance for FY15 when it reports Q1 results.
08:34 EDTNUVANuVasive CEO steps down, Gregory Lucier appointed chairman, interim CEO
Subscribe for More Information
07:23 EDTDGXQuintiles deal positive, says Wells Fargo
Subscribe for More Information
March 31, 2015
14:55 EDTBSXBoston Scientific volatility at historic lows as shares near eight-year high
Subscribe for More Information
06:57 EDTDGXQuintiles and Quest Diagnostics to host joint conference call
Conference call to discuss joint venture to form a global clinical trials laboratory services business will be held on March 31 at 8:30 am. Webcast Link
06:03 EDTDGXQuintiles and Quest Diagnostics to form JV to provide clinical trials services
Subscribe for More Information
March 30, 2015
10:52 EDTDGXLeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information
March 27, 2015
10:03 EDTDGXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:12 EDTDGXQuest Diagnostics initiated with a Market Perform at JMP Securities
March 25, 2015
10:00 EDTDGXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AB InBev (BUD) downgraded to Reduce from Overweight at HSBC... BreitBurn Energy (BBEP) downgraded to Sell from Neutral at UBS... DiamondRock (DRH) downgraded to Reduce from Neutral at SunTrust... Ethan Allen (ETH) downgraded to Hold from Buy at Gabelli... Felcor Lodging (FCH) downgraded to Neutral from Buy at SunTrust... Finish Line (FINL) downgraded to Neutral from Buy at B. Riley... Hannover Re (HVRRY) downgraded to Sell from Hold at Deutsche Bank... Hersha Hospitality (HT) downgraded to Reduce from Neutral at SunTrust... Host Hotels (HST) downgraded to Reduce from Neutral at SunTrust... ING Groep (ING) downgraded to Neutral from Buy at Goldman... Informatica (INFA) downgraded to Neutral from Buy at Mizuho... Kofax (KFX) downgraded to Hold from Buy at Canaccord... LRR Energy (LRE) downgraded to Sell from Neutral at UBS... LaSalle Hotel (LHO) downgraded to Reduce from Neutral at SunTrust... Munich Re (MURGY) downgraded to Sell from Hold at Deutsche Bank... Orbital ATK (OA) downgraded to Market Perform from Outperform at Wells Fargo... PCTEL, Inc. (PCTI) downgraded to Neutral from Buy at B. Riley... Quest Diagnostics (DGX) downgraded to Hold from Buy at Deutsche Bank... SJW Corp. (SJW) downgraded to Neutral from Outperform at RW Baird... Selective Insurance (SIGI) downgraded to Neutral from Buy at BofA/Merrill... Sonus (SONS) downgraded to Hold from Buy at Wunderlich... Starwood (HOT) downgraded to Neutral from Buy at SunTrust... Synchrony Financial (SYF) downgraded to Neutral from Buy at BofA/Merrill... Tesla (TSLA) downgraded to Underperform from Outperform at CLSA... Twitter (TWTR) downgraded to Hold from Buy at Pivotal Research... ZAGG (ZAGG) downgraded to Market Perform from Outperform at Northland... iDreamSky (DSKY) downgraded to Neutral from Overweight at JPMorgan.
07:12 EDTDGXQuest Diagnostics downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
March 24, 2015
16:06 EDTBSXBoston Scientific announces first commercial procedures with Watchman Device
This week, three patients in the U.S. received the first implants of the Boston Scientific Watchman Left Atrial Appendage Closure, or LAAC, Device. The WATCHMAN Device offers a novel stroke risk reduction option for high-risk patients with non-valvular atrial fibrillation, or AF, who are seeking an alternative to long-term warfarin therapy. The Watchman Device received FDA approval on Friday, March 13. The first Watchman Device procedures in the U.S. were performed by Shephal K. Doshi, M.D., director of Cardiac Electrophysiology and Pacing at Saint John's Health Center in Santa Monica, CA, and Saibal Kar, M.D., director of the Cardiovascular Intervention Center Research at Cedars-Sinai Hospital in Los Angeles, CA.
07:34 EDTNUVACanaccord to hold a conference
Musculoskeletal Conference is being held in Las Vegas on March 24.
March 23, 2015
16:19 EDTBSXBoston Scientific leads funding round for InterVene
Subscribe for More Information
08:31 EDTELGXStephens healthcare analysts hold an analyst/industry conference call
Subscribe for More Information
March 20, 2015
11:41 EDTCMNCantel Medical names Peter Clifford as CFO
Subscribe for More Information
10:00 EDTBSXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:32 EDTBSXBoston Scientific has a conference call hosted by JPMorgan
JPMorgan Analyst Weinstein will host a conference call with CEO Mike Mahoney on March 27 at 11 am.
06:44 EDTBSXBoston Scientific initiated with an Outperform at Raymond James
Subscribe for More Information
March 19, 2015
10:02 EDTABCOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use